These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4061127)

  • 1. Plasma exchange in the treatment of heterozygous familial hypercholesterolaemia.
    van de Wiel A; Kruiswijk T; de Gruijter J; Hart HC; Imhof JW
    Acta Med Scand; 1985; 218(2):233-9. PubMed ID: 4061127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plasma exchange on serum cholesterol levels in heterozygous familial hypercholesterolemia.
    van de Wiel A; Kruiswijk T; Imhof JW; Hart HC; Holtkamp HC; Szakaly M
    Acta Med Scand; 1981; 210(6):461-5. PubMed ID: 7331893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy.
    Eriksson M; Lantz B; Berglund L; Angelin B
    Acta Med Scand; 1987; 221(3):317-20. PubMed ID: 3591471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
    Keller C; Hailer S; Demant T; Wolfram G; Zöllner N
    Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments.
    Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G
    Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776
    [No Abstract]   [Full Text] [Related]  

  • 8. Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia.
    Leren TP; Fagerhol MK; Leren P
    J Intern Med; 1993 Feb; 233(2):195-200. PubMed ID: 8433081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
    Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR
    BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.
    Sugrue DD; Trayner I; Thompson GR; Vere VJ; Dimeson J; Stirling Y; Meade TW
    Br Heart J; 1985 Mar; 53(3):265-8. PubMed ID: 3970784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
    Leitersdorf E; Muratti EN; Eliav O; Meiner V; Eisenberg S; Dann EJ; Sehayek E; Peters TK; Stein Y
    Am J Med; 1994 May; 96(5):401-7. PubMed ID: 8192170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia.
    Brook G; Winterstein G; Aviram M
    Clin Sci (Lond); 1983 Jun; 64(6):637-42. PubMed ID: 6839669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
    Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
    Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Cheung J; Crook MA
    QJM; 1997 Oct; 90(10):631-4. PubMed ID: 9415344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
    Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
    Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 17. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
    Raal FJ; Stein EA; Dufour R; Turner T; Civeira F; Burgess L; Langslet G; Scott R; Olsson AG; Sullivan D; Hovingh GK; Cariou B; Gouni-Berthold I; Somaratne R; Bridges I; Scott R; Wasserman SM; Gaudet D;
    Lancet; 2015 Jan; 385(9965):331-40. PubMed ID: 25282519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
    Mabuchi H; Koizumi J; Kajinami K
    Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.